Risk of lymphoid malignancy associated with cancer predisposition genes - Summary - MDSpire

Risk of lymphoid malignancy associated with cancer predisposition genes

  • By

  • Nicholas J. Boddicker

  • Raphael Mwangi

  • Dennis P. Robinson

  • Cristine Allmer

  • Allison C. Rosenthal

  • Thomas M. Habermann

  • Andrew L. Feldman

  • Lisa M. Rimsza

  • Rebecca L. King

  • Melissa C. Larson

  • Bri J. Negaard

  • Aaron D. Norman

  • Nikhil Rajkumar

  • Stephen M. Ansell

  • Angela Dispenzieri

  • David L. Murray

  • Vincent Rajkumar

  • Shaji Kumar

  • Jithma P. Abeykoon

  • Grzegorz S. Nowakowski

  • Thomas E. Witzig

  • Anne J. Novak

  • Susan L. Slager

  • Celine M. Vachon

  • James R. Cerhan

  • April 19, 2025

  • 0 min

Share

Objective:

To investigate the association between pathogenic variants in cancer predisposition genes, specifically focusing on those related to DNA damage repair, and the risk of lymphoid malignancies (LM) and major LM subtypes.

Key Findings:
  • Family history of specific LM subtypes significantly increases the risk of the same subtype, with [insert specific statistics].
  • Pathogenic variants in genes associated with DNA damage repair, such as [insert specific genes], may increase the risk of LM.
  • Suggestive evidence links increased lymphoma incidence to syndromes like Li Fraumeni and Lynch Syndrome, with [insert specific findings].
Interpretation:

The study highlights the potential role of genetic predisposition in the risk of lymphoid malignancies, suggesting that pathogenic variants in certain genes may contribute to this risk, which could inform genetic counseling and testing strategies.

Limitations:
  • The understanding of the relationship between pathogenic variants and LM risk is still limited, particularly regarding the general population.
  • Further research with larger sample sizes is needed to clarify the prevalence of pathogenic variants and their association with LM subtypes, as well as to address potential biases in sample collection.
Conclusion:

This research underscores the importance of genetic testing in assessing the risk of lymphoid malignancies and suggests a need for further studies to elucidate the genetic factors involved, emphasizing the urgency for more comprehensive research.

Original Source(s)

Risk of lymphoid malignancy associated with cancer predisposition genes

  • by Nicholas J. Boddicker, Raphael Mwangi, Dennis P. Robinson, Cristine Allmer, Allison C. Rosenthal, Thomas M. Habermann, Andrew L. Feldman, Lisa M. Rimsza, Rebecca L. King, Melissa C. Larson, Bri J. Negaard, Aaron D. Norman, Nikhil Rajkumar, Stephen M. Ansell, Angela Dispenzieri, David L. Murray, Vincent Rajkumar, Shaji Kumar, Jithma P. Abeykoon, Grzegorz S. Nowakowski, Thomas E. Witzig, Anne J. Novak, Susan L. Slager, Celine M. Vachon, James R. Cerhan

  • April 19, 2025

Related Content

Short-term cardiotoxicity and early echocardiographic changes following autologous hematopoietic stem cell transplantation: a single-center retrospective analysis

Hodgkin lymphoma with hypereosinophilia in a pediatric patient: case report and review of the literature

Enhancing targeted strategies for cancer immunotherapy by elucidating mRNA processing mechanisms